Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.
about
Positron emission tomography imaging of prostate cancerUpdate on positron emission tomography for imaging of prostate cancerImaging on nodal staging of prostate cancer.Detection rate of PET/CT in patients with biochemical relapse of prostate cancer using [68Ga]PSMA I&T and comparison with published data of [68Ga]PSMA HBED-CC.Non-invasive molecular imaging of prostate cancer lymph node metastasis.Restricted water diffusibility as measured by diffusion-weighted MR imaging and choline uptake in (11)C-choline PET/CT are correlated in pelvic lymph nodes in patients with prostate cancer.Clinical Utility of Gallium-68 PSMA PET/CT Scan for Prostate Cancer.Consequence of the introduction of routine FCH PET/CT imaging for patients with prostate cancer: a dual centre survey.Comparative performance of PET tracers in biochemical recurrence of prostate cancer: a critical analysis of literature.A system for evaluating magnetic resonance imaging of prostate cancer using patient-specific 3D printed molds.Noninvasive Imaging of PSMA in prostate tumors with (89)Zr-Labeled huJ591 engineered antibody fragments: the faster alternativesImaging and cancer: a review.The diagnostic value of PET/CT imaging with the (68)Ga-labelled PSMA ligand HBED-CC in the diagnosis of recurrent prostate cancer.The next generation of positron emission tomography radiopharmaceuticals in oncology.Targeted salvage lymphadenectomy in patients treated with radical prostatectomy with biochemical recurrence: complete biochemical response without adjuvant therapy in patients with low volume lymph node recurrence over a long-term follow-up.New agents and techniques for imaging prostate cancer.PET/CT Imaging and Radioimmunotherapy of Prostate CancerDetection of recurrent prostate cancer with 18F-fluorocholine PET/CT in relation to PSA level at the time of imaging.PSMA PET/CT with Glu-urea-Lys-(Ahx)-[⁶⁸Ga(HBED-CC)] versus 3D CT volumetric lymph node assessment in recurrent prostate cancerGeneralized whole-body Patlak parametric imaging for enhanced quantification in clinical PETImaging localized prostate cancer: current approaches and new developments.Integration of (68)Ga-PSMA-PET imaging in planning of primary definitive radiotherapy in prostate cancer: a retrospective study.Choline autoradiography of human prostate cancer xenograft: effect of castrationManagement of prostate cancer patients with lymph node involvement: a rapidly evolving paradigm.Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer.RapidArc, intensity modulated photon and proton techniques for recurrent prostate cancer in previously irradiated patients: a treatment planning comparison study.Positron emission tomography/computed tomography and radioimmunotherapy of prostate cancer.Application of metabolic PET imaging in radiation oncology.68Ga-PSMA-11 PET/CT for prostate cancer staging and risk stratification in Chinese patients.Quantitative 18F-fluorocholine positron emission tomography for prostate cancer: correlation between kinetic parameters and Gleason scoring.Modalities for imaging of prostate cancer.18F-fluorocholine for prostate cancer imaging: a systematic review of the literature.Lymph Node Staging with Choline PET/CT in Patients with Prostate Cancer: A Review.Imaging in prostate cancer staging: present role and future perspectives.Imaging with non-FDG PET tracers: outlook for current clinical applications.Role of choline PET/CT in guiding target volume delineation for irradiation of prostate cancer.18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients.Choline PET/CT for imaging prostate cancer: an update.Individualized image-based lymph node irradiation for prostate cancer.A paradigm shift from anatomic to functional and molecular imaging in the detection of recurrent prostate cancer.
P2860
Q24596241-111396E8-2FF4-49E1-9D85-A9DE99F3E3A2Q27026828-DF0D38BD-506F-4AA9-80A9-6AF4599BC450Q30244033-3C0B5886-04EC-4858-BB4A-23A958BB035FQ31145236-93C9B2EA-A3DA-4474-896A-12AB27C600E8Q33557567-42FC9E63-DF97-42E7-8F8A-2D3167F12ED8Q33583831-F7927A35-1BC9-4373-BBBD-1C8FCBF5073CQ33711641-6B02C9CC-7EAD-409E-8A92-FC8846356CD1Q34040036-EF825040-162E-4F66-8D84-6B7BC9002440Q34228828-0F94752A-2663-42A1-BCC3-77A1E4D68026Q34448206-BD261401-6222-436F-AEF5-174383C4FC1DQ34473460-7DDF1A80-7203-4054-B83E-8CEFA2936073Q34977050-71D447C6-BFEC-4716-B1F1-759CE6EC568CQ35043569-E86BC28F-125E-4C36-9DE1-AAA9BD6613EBQ35525690-1CE48A68-121E-4391-8457-CCEE01E00D3DQ35604502-887FAC9C-9C21-4C48-81A5-5A805601BBA8Q35911784-6262F122-C831-4ABC-95D4-BED3554FC214Q36085426-51CD69DF-7B66-4EDB-9E67-FCDFBDE63EAAQ36103698-A396F215-DD7C-4580-B33E-B33CEB00DFEAQ36109230-8C95C35F-B100-4E21-9AA2-A2E95A98C335Q36454757-329D8D27-F10E-473A-A673-62EFE375FFF4Q36469177-1A424313-869A-4345-B2F4-1CA061942D89Q36942136-C0400B27-F7E8-4F96-A4E5-AA46E457794BQ37052606-2AF92C31-306C-4B60-BBB9-2A0FA64EC240Q37086178-96CB24CB-DB24-4A7F-AC87-125C3CA24101Q37350456-2D9B7603-640D-456F-82DA-40B2009B6BEDQ37357942-F0F0B9A5-E3BD-497C-BD8C-9848EEF7D27DQ37457888-5CBB4B06-E4E9-4A1C-852C-3D60F87F6FCEQ37580845-AB315269-B886-461A-82FA-D43E14A6BD47Q37707083-811AE8F5-E200-43E0-9872-90D9BE002C1BQ37714485-009D6934-0ED4-4D3C-BB73-0BF84E64A474Q37719273-08903BC5-3571-4320-97D1-BE6BDD78A3B4Q37918311-8E9AEF28-F3AF-4785-B022-4C141AFF1E48Q37973351-14C65B58-AED0-44A3-917C-6A293251AD5DQ37979650-1152EE6C-E73D-4F40-A911-E6CD387C72E5Q37986065-536CA8C2-64AE-46CE-B92B-E211EEB95B7AQ38098124-9DDC244D-08F0-465B-97A6-EF2AB2C66ACAQ38098441-4DB07C43-1B0D-4513-A7F2-C37C24F7D849Q38103180-1BCEB410-166E-4CEA-A3D0-969894A72ECEQ38109812-FADF6B22-82AA-4B6E-B524-C61906F6B7BEQ38190115-1AF993AD-C1CB-4B15-B4B0-BCB73661BF8F
P2860
Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.
description
2007 nî lūn-bûn
@nan
2007 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Evaluation of [
@nl
Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.
@ast
Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.
@en
type
label
Evaluation of [
@nl
Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.
@ast
Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.
@en
prefLabel
Evaluation of [
@nl
Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.
@ast
Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer.
@en
P2093
P1476
Evaluation of [(18)F]-choline PET/CT for staging and restaging of prostate cancer
@en
P2093
Albert Gelet
Hubert John
Markus Dubs
Olivier T Giger
Raymond Miralbell
Thomas F Hany
Tibor Cservenyàk
P2888
P304
P356
10.1007/S00259-007-0552-9
P577
2007-10-10T00:00:00Z